Bayer's Nexavar Found Too Expensive in the UK from spicyipindia.blogspot.com Even as Bayer has challenged a
Delhi High Court decision refusing to import the problematic concept of "patent linkage" to India (hearings at the appellate court have concluded and we now await a decision), Gauri ...
Share via E–mail | Twitter | Facebook
Reviewing the Indian Patent Regime After 5 Years from spicyipindia.blogspot.com Jyothi Datta of the
Hindu Business Line has an interesting write up, documenting reactions after 5 years of the introduction of the pharmaceutical product patent regime in India. She also has a
separate write up ... Share via E–mail | Twitter | Facebook
Arguing for free "green patents": a twice-told story? from ipbiz.blogspot.com In an opinion piece in the Christian Science Monitor titled
In a Wikipedia age, should all ideas be free?, William F. Shughart II (an economics professor at UMiss) excoriates Lawrence Lessig, a law prof now ...
Share via E–mail | Twitter | Facebook